Is the EQ-5D a Valid Instrument to Assess Health Related Quality of Life of Psoriasis Patients?
Jenny M. Norlin
Abstract
Jenny M. Norlin
Abstract
The purpose of this paper was to investigate whether EQ-5D is a valid measure of Health Related Quality of Life of psoriasis patients. The objective was carried out by investigating the correlation between the EuroQol EQ-5D and two other Health Related Quality of Life measures, Dermatology Life Quality Index and a Visual Analogue Scale assessed by the patient, as well as two clinical outcome measures assessed by the physician. Furthermore, the objective was to investigate whether the EQ-5D systematically differs from the other Health Related Quality of Life measures. The quality of life was measured in 2085 patients with psoriasis in PsoReg, a national registry for psoriasis patients in Sweden. Dermatology Life Quality Index has shown to be a valid measure in psoriasis patients in previous research and it correlated moderately with the EQ-5D in this study. There was a low significant correlation between the EQ-5D and the clinical outcome measures. Limited evidence implies that the EQ- 5D differs systematically from the other quality of life measures regarding age. This study suggests that the EQ-5D is a valid measure of Health Related Quality of life of psoriasis patients. Nevertheless, both generic and disease-specific instruments can contribute in the assessment of quality of life of patients with psoriasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The purpose of this paper was to investigate whether EQ-5D is a valid measure of Health Related Quality of Life of psoriasis patients. The objective was carried out by investigating the correlation between the EuroQol EQ-5D and two other Health Related Quality of Life measures, Dermatology Life Quality Index and a Visual Analogue Scale assessed by the patient, as well as two clinical outcome measures assessed by the physician. Furthermore, the objective was to investigate whether the EQ-5D systematically differs from the other Health Related Quality of Life measures. The quality of life was measured in 2085 patients with psoriasis in PsoReg, a national registry for psoriasis patients in Sweden. Dermatology Life Quality Index has shown to be a valid measure in psoriasis patients in previous research and it correlated moderately with the EQ-5D in this study. There was a low significant correlation between the EQ-5D and the clinical outcome measures. Limited evidence implies that the EQ- 5D differs systematically from the other quality of life measures regarding age. This study suggests that the EQ-5D is a valid measure of Health Related Quality of life of psoriasis patients. Nevertheless, both generic and disease-specific instruments can contribute in the assessment of quality of life of patients with psoriasis.
Key concepts: Psoriasis, Quality of life (healthcare), EQ-5D, Medicine, Psoriasis Area and Severity Index, Dermatology Life Quality Index, Patient-reported outcome, Scale (ratio)